36 related articles for article (PubMed ID: 16168561)
1. Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.
Leo J; Dondossola E; Basham KJ; Wilson NR; Alhalabi O; Gao J; Kurnit KC; White MG; McQuade JL; Westin SN; Wellberg EA; Frigo DE
Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37154098
[TBL] [Abstract][Full Text] [Related]
2. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma.
Rodolakis A; Scambia G; Planchamp F; Acien M; Di Spiezio Sardo A; Farrugia M; Grynberg M; Pakiž M; Pavlakis K; Vermeulen N; Zannoni G; Zapardiel I; Tryde Macklon KL
Facts Views Vis Obgyn; 2023 Mar; 15(1):3-23. PubMed ID: 37010330
[TBL] [Abstract][Full Text] [Related]
3. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
Rodolakis A; Scambia G; Planchamp F; Acien M; Di Spiezio Sardo A; Farrugia M; Grynberg M; Pakiz M; Pavlakis K; Vermeulen N; Zannoni G; Zapardiel I; Macklon KLT
Hum Reprod Open; 2023; 2023(1):hoac057. PubMed ID: 36756380
[TBL] [Abstract][Full Text] [Related]
4. Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer.
Gelissen JH; Huang GS
Front Oncol; 2022; 12():914405. PubMed ID: 36052252
[TBL] [Abstract][Full Text] [Related]
5. Analysis of immunohistochemical characteristics and recurrence after complete remission with fertility preservation treatment in patients with endometrial carcinoma and endometrial atypical hyperplasia.
Li L; Xiao Z; Wang Y; He Y; Wang Z; Shen D; Wang J
Arch Gynecol Obstet; 2023 Jun; 307(6):2025-2031. PubMed ID: 35098335
[TBL] [Abstract][Full Text] [Related]
6. A Novel Prognostic Model of Endometrial Carcinoma Based on Clinical Variables and Oncogenomic Gene Signature.
Deng F; Mu J; Qu C; Yang F; Liu X; Zeng X; Peng X
Front Mol Biosci; 2020; 7():587822. PubMed ID: 33490103
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer.
Wang C; Tran DA; Fu MZ; Chen W; Fu SW; Li X
J Cancer; 2020; 11(7):1693-1701. PubMed ID: 32194781
[No Abstract] [Full Text] [Related]
8. Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis.
Chiu HC; Li CJ; Yiang GT; Tsai AP; Wu MY
J Clin Med; 2019 Mar; 8(4):. PubMed ID: 30935077
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor suppressor programmed cell death 4 in endometrioid endometrial carcinomas and clinicopathological significance.
Liu Y; Sun H; Mao H; Gao M; Tan X; Li Y; Li Y; Muloye GM; Zhang L; Wang X; Wei Z
Oncol Lett; 2018 Jun; 15(6):9369-9376. PubMed ID: 29805661
[TBL] [Abstract][Full Text] [Related]
10. Association between HSD17B1 rs605059 polymorphisms and the risk of uterine diseases: a systemic review and meta-analysis.
Mu X; Du X; Yao K; Zhao J; Bian C; Wang Q; Ma H; Yi T; Wu Y; Zhao X
Int J Clin Exp Pathol; 2015; 8(6):6012-8. PubMed ID: 26261478
[TBL] [Abstract][Full Text] [Related]
11. The EMT signaling pathways in endometrial carcinoma.
Colas E; Pedrola N; Devis L; Ertekin T; Campoy I; Martínez E; Llauradó M; Rigau M; Olivan M; Garcia M; Cabrera S; Gil-Moreno A; Xercavins J; Castellvi J; Garcia A; Ramon y Cajal S; Moreno-Bueno G; Dolcet X; Alameda F; Palacios J; Prat J; Doll A; Matias-Guiu X; Abal M; Reventos J
Clin Transl Oncol; 2012 Oct; 14(10):715-20. PubMed ID: 22911547
[TBL] [Abstract][Full Text] [Related]
12. Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
van der Horst PH; Wang Y; Vandenput I; Kühne LC; Ewing PC; van Ijcken WF; van der Zee M; Amant F; Burger CW; Blok LJ
PLoS One; 2012; 7(1):e30840. PubMed ID: 22295114
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
[TBL] [Abstract][Full Text] [Related]
14. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
16. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature.
Mariani A; Sebo TJ; Katzmann JA; Riehle DL; Dowdy SC; Keeney GL; Lesnick TG; Podratz KC
Anticancer Res; 2005; 25(4):2921-7. PubMed ID: 16080545
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium.
Mylonas I; Makovitzky J; Friese K; Jeschke U
Acta Histochem; 2009; 111(4):349-59. PubMed ID: 19195687
[TBL] [Abstract][Full Text] [Related]
18. Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication.
Jeon YT; Park IA; Kim YB; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Lett; 2006 Aug; 239(2):198-204. PubMed ID: 16168561
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
